VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 181 filers reported holding VANDA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $673,920 | -34.4% | 156,000 | 0.0% | 0.13% | -31.7% |
| Q2 2023 | $1,028,040 | -2.9% | 156,000 | 0.0% | 0.19% | +13.9% |
| Q1 2023 | $1,059,240 | -8.1% | 156,000 | 0.0% | 0.17% | -11.7% |
| Q4 2022 | $1,152,840 | -25.2% | 156,000 | 0.0% | 0.19% | -29.3% |
| Q3 2022 | $1,541,000 | -9.4% | 156,000 | 0.0% | 0.27% | -9.2% |
| Q2 2022 | $1,700,000 | -3.6% | 156,000 | 0.0% | 0.29% | -14.6% |
| Q1 2022 | $1,764,000 | -27.9% | 156,000 | 0.0% | 0.34% | -36.1% |
| Q4 2021 | $2,448,000 | +15.2% | 156,000 | +25.8% | 0.54% | +14.7% |
| Q3 2021 | $2,125,000 | +6.2% | 124,000 | +33.3% | 0.47% | +13.0% |
| Q2 2021 | $2,000,000 | +85.0% | 93,000 | +29.2% | 0.41% | +85.7% |
| Q1 2021 | $1,081,000 | +61.3% | 72,000 | +41.2% | 0.22% | +26.7% |
| Q4 2020 | $670,000 | +98.2% | 51,000 | +45.7% | 0.18% | +97.8% |
| Q3 2020 | $338,000 | – | 35,000 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
| Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
| Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
| Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
| EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
| Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
| EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
| UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
| ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
| 361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |